<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00673894</url>
  </required_header>
  <id_info>
    <org_study_id>H07/059</org_study_id>
    <nct_id>NCT00673894</nct_id>
  </id_info>
  <brief_title>Effects of Glutamine on GLP-1 and Insulin Secretion in Man</brief_title>
  <official_title>Study of the Effects of Glutamine on GLP-1, Insulin Secretion and Glycaemia in Man</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Garvan Institute of Medical Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Garvan Institute of Medical Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the effect of glutamine, an amino acid, on GLP-1, insulin and
      glycaemia in normal lean subjects and patients with type 2 diabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, will investigate the effect of glutamine, an amino acid, on GLP-1, insulin and
      glycaemia in normal lean subjects and patients with type 2 diabetes. Preliminary data
      published by our group suggests that glutamine is a strong determinant of GLP-1 secretion in
      vitro. We will test the hypothesis that glutamine lowers post-prandial glucose levels. We
      will also investigate whether sitagliptin modifies this effect.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2008</start_date>
  <completion_date type="Anticipated">June 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-prandial glucose</measure>
    <time_frame>180 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>GLP-1</measure>
    <time_frame>180 min</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Type 2 Diabetes</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glutamine, sitagliptin</intervention_name>
    <description>Glutamine 15g and 30g/sitagliptin 100mg</description>
    <other_name>Januvia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy subjects (lean) or type 2 diabetes, on metformin or diet alone (not
             sulphonylureas or insulin)

        Exclusion Criteria:

          -  malabsorption, renal or liver disease, using steroids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jerry R Greenfield</last_name>
    <phone>612-9295-8217</phone>
    <email>j.greenfield@garvan.org.au</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinical Research Facility</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr J Greenfield, FRACP</last_name>
      <phone>612-9295-8100</phone>
      <phone_ext>8217</phone_ext>
      <email>j.greenfield@garvan.org.au</email>
    </contact>
    <investigator>
      <last_name>Jerry Greenfield, FRACP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2008</study_first_submitted>
  <study_first_submitted_qc>May 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2008</study_first_posted>
  <last_update_submitted>June 19, 2008</last_update_submitted>
  <last_update_submitted_qc>June 19, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2008</last_update_posted>
  <responsible_party>
    <name_title>Jerry Greenfield</name_title>
    <organization>Garvan Institute of Medical Research</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sitagliptin Phosphate</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>September 21, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

